January 10, 2023
Dr. Grant brings to the table significant BOD governance, global business development, and corporate development expertise Half Moon Bay, CA. – GenNext Technologies, Inc., an innovative provider of laboratory tools for advanced structural characterization of proteins, announced today that Dr. John L. Grant has joined its Board of Directors.Dr. Grant served as a highly valuable mentor for [...]
Park Systems Introduces Park NX-IR R300 Infrared Spectroscopy for Semiconductor Industry
January 9, 2023
Park Systems, a leading manufacturer of atomic force microscopy (AFM) and nano metrology systems, has introduced its newest product, the Park NX-IR R300, a nanoscale infrared spectroscopy (IR) system for industrial applications. Park NX-IR R300 is an infrared spectroscopy and atomic force microscopy integrated into one, for up to 300 mm semiconductor wafers. It provides [...]
LuminUltra participates in innovative wastewater surveillance pilot project at Toronto Pearson
January 9, 2023
FREDERICTON, CANADA – LuminUltra has partnered with the Greater Toronto Airports Authority (GTAA) to implement a cutting-edge, on-site laboratory to perform wastewater surveillance testing at Pearson International Airport. This pilot project, supported in part by funding from the National Research Council of Canada Industrial Research Assistance Program, is using LuminUltra’s technology to test for the [...]
BC Platforms Selected as Partner to Deliver key Singapore Population Health Study
January 9, 2023
First-in-kind Singapore study to deliver insights into heart disease, diabetes, cancer, and other chronic diseases BC Platforms (BCP), a global leader in healthcare data management and analytics, today announced it has been selected as the platform of choice to analyse and manage data collected from the Health for Life in Singapore (HELIOS) study, which forms part of [...]
January 9, 2023
Making proteomics 100x more robust and 10x faster ODENSE, DENMARK – Evosep Aps – Evosep today announced that Novo Holdings A/S has become a minority shareholder in Evosep Aps with a US$ 40m investment to further Evosep’s technology and application portfolio for clinical proteomics. Evosep aims to improve quality of life and patient care by [...]
Novo Holdings invests in proteomics technology company, Evosep
January 9, 2023
COPENHAGEN, Denmark -- Novo Holdings, a leading international life science investor, today announced a $40m investment in Evosep, the bioscience company leading the standardisation of proteomics for clinical use. The proceeds from the investment by Novo Holdings will be used to advance clinical applications of proteomics enabled by Evosep's standardised liquid chromatography platform. The new funds will [...]
Berkeley Lights Launches Beacon Select™, A New Optofluidic System For Cell Line Development
January 9, 2023
New, two-chip, single-cell optofluidic system ideal for small- to mid-sized biopharma & CDMOs/CROs to affordably gain access to the Beacon® technology and cell line development-specific applications EMERYVILLE, Calif. -- Berkeley Lights, Inc. (Nasdaq: BLI), a life sciences tools company, today announced the launch of the Beacon Select™, the company's new optofluidic system for cell line development (CLD). The [...]
Quanterix Announces Appointment Of Brian Blaser To Board Of Directors
January 9, 2023
BILLERICA, Mass. – Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that it has appointed Brian Blaser to its Board of Directors effective as of January 6, 2023. Mr. Blaser brings over 25 years of senior leadership experience in the in-vitro diagnostics industry, including 15 years at Abbott Laboratories where he was responsible [...]
January 9, 2023
Eschborn - Germany - AnalytiChem Holding GmbH today has announced the acquisition of bioTRADING Benelux B.V., a Dutch manufacturer of high-quality culture media in all forms of packaging. Founded in 1979, bioTRADING Benelux B.V. serves customers in a wide range of industries from pharmaceutical, veterinarian and food industries to hospitals, pharmacies and also supplies to regional [...]
Illumina and Nashville Biosciences Announce Sequencing Agreement with Amgen
January 9, 2023
Whole-genome sequencing of 35,000 de-identified, diverse genomic DNA samples will begin this month SAN DIEGO -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, and Nashville Biosciences LLC, a wholly owned subsidiary of Vanderbilt University Medical Center (VUMC), today announced an agreement with Amgen, a global biopharmaceutical company, to whole-genome sequence [...]

